<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01822301</url>
  </required_header>
  <id_info>
    <org_study_id>PRO12100585</org_study_id>
    <nct_id>NCT01822301</nct_id>
  </id_info>
  <brief_title>Structural Fat Grafting for Craniofacial Trauma: Repeat Fat Grafting Injection-5 Subject Cohort</brief_title>
  <acronym>BTIPlusUp</acronym>
  <official_title>Structural Fat Grafting for Craniofacial Trauma: Repeat Fat Grafting Injection-5 Subject Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Department of Defense</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fat grafting represents a technique with great potential to improve outcomes in minimally
      invasive facial reconstruction. Fat grafting has already been demonstrated as a safe and
      minimally invasive technique over decades of widespread practice in plastic surgery. In our
      current study of fat grafting for facial deformities (IRB# PRO09060101), we have treated 9
      subjects without adverse event and all have had a significant improvement. Since all methods
      of treatment and evaluation are the same in this study, we will be able to use the data in
      our prior study as additional control data.

      We hypothesize that repeating the fat grafting in subjects with previous facial fat grafts
      will enable successful restoration of tissue volume and craniofacial form. Additionally, we
      hypothesize that the results will be durable and subject quality of life improved.

      Five (5) subjects (who were previously enrolled into IRB# PRO09060101) will be enrolled to
      this single center University of Pittsburgh site research study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Facial trauma injuries, especially those sustained in military combat and severe automobile
      crashes, are characterized by destruction of bone and soft tissue anatomy. While the bony
      skeleton can often be reconstructed, the overlying soft tissue is difficult to restore.

      Importantly, it is the structure of the soft tissue that imparts the normal human form, and
      adequate reconstruction of soft tissue defects allows trauma victims to reintegrate into
      society. Accepted procedures for soft tissue reconstruction of the face involve tissue flap
      reconstruction procedures and autologous fat grafting. Tissue flap operations are extensive,
      often including microvascular surgery, and do not precisely correct the deformities. Fat
      grafting is a less invasive technique that allows for more precise shaping of the
      reconstructed tissues. However, autologous fat grafts may undergo resorption that can affect
      the appearance of the reconstruction over time. The degree of change in appearance after fat
      grafting has not been well studied for facial trauma patients.

      We hypothesize that subjects who have successfully completed participation in the study
      (PRO09060101) and experienced graft resorbtion will have improved outcomes with an additional
      fat graft treatment. We anticipate that additional fat graft treatment will fully restore the
      facial features and overcome fat loss from the initial fat graft treatment. Additionally, we
      hypothesize that the cellular properties of the fat precursor cells (preadipocytes) may
      correlate with fat graft retention
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Facial Volume Score</measure>
    <time_frame>assessed at baseline (pre-op), days 7-21 post-op, 3 months post-op, and 9 months post-op</time_frame>
    <description>the facial volume and appearance grading scale evaluates each aesthetic region in the face based on both physical examination and 3D photography by the clinician. scale ranges from 1-3 where a score of 1 indicates an obvious contour defect; 2 shows a noticeable improvement in contour but not sufficient to impart a normal appearance; 3 represents a normal appearance and/or close approximation with a normal uninjured contralateral structure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serial Computed Tomography Imaging</measure>
    <time_frame>assessed at 7-21 days, 3 months and 9 months post op.</time_frame>
    <description>serial computed tomography images were collected to evaluate the volume of the defect</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Facial Injuries</condition>
  <condition>Adipose Tissue</condition>
  <arm_group>
    <arm_group_label>Repeat Facial fat grafting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Repeat Fat grafting</intervention_name>
    <description>Fat grafting is a minimally invasive clinical procedure that has been widely used by plastic surgeons within reconstructive surgery for many years. Fat grafting is considered a standard of care procedure in plastic surgery. In brief, fat tissue to be used for grafting is harvested (usually from abdomen or thighs) with a small liposuction cannula in the operating room. The fat tissue is then sterilely centrifuged and allowed to decant before separating the fluid and oil layers from the fat tissue fraction. The aspirated fat is then loaded into 1cc syringes and injected into the facial deformity using specialized injection cannulas. In this study, we will treat 5 subjects from protocol (IRB # PRO09060101) with an additional fat graft treatment to assess whether this will increase fat graft retention over time. Additionally, data from our current study assessing volume retention after fat grafting for facial deformities (IRB # PRO09060101) with be used for comparison.</description>
    <arm_group_label>Repeat Facial fat grafting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged 18 years or older and able to provide informed consent

          2. Have suffered injury resulting in craniofacial volume defects which could be treated
             with a graft volume of between 5 and 150 cc of lipoaspirate

          3. Be at least 3 months post-injury or post-surgery (from trauma procedures) so that
             acute edema is resolved

          4. Volume defects are covered by intact skin and do not communicate with oral cavity or
             sinuses

          5. The three dimensional geometry of the volume defects would allow for treatment with
             lipoaspirate injection that in a manner that at least two distinct treated areas could
             be discerned on gross examination and radiographically (e.g. treated regions are on
             opposite sides of the face, on lower face versus upper face, or separated by a bony
             landmark such as zygoma. This would include the ability to treat an uninjured
             contralateral region with lipaspirate in order to obtain symmetry.

          6. Willing and able to comply with follow up examinations, including radiographic studies

          7. Have completed participation in IRB# PRO09060101.

        Exclusion Criteria:

          1. Age less than 18 years

          2. Inability to provide informed consent

          3. Craniofacial defects intended for treatment have open wounds or communicate with oral
             cavity or sinus (note: presence of such a defect in the setting of another defect(s)
             that meets treatment criteria will not exclude the patient from participating).

          4. Active infection anywhere in the body

          5. Diagnosed with cancer within the last 12 months and /or presently receiving
             chemotherapy or radiation treatment

          6. Known coagulopathy

          7. Systemic disease that would render the fat harvest and injection procedure, along with
             associated anesthesia, unsafe to the patient.

          8. Pregnancy

          9. Subjects with Schizophrenia, Bipolar Disorder. (Subjects who are found to be stable on
             medication and receive psychiatric clearance could be eligible for study participation
             per the Physician's discretion.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph P Rubin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unversity of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Moseley TA, Zhu M, Hedrick MH. Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg. 2006 Sep;118(3 Suppl):121S-128S. Review.</citation>
    <PMID>16936551</PMID>
  </reference>
  <reference>
    <citation>Cárdenas JC, Carvajal J. Refinement of rhinoplasty with lipoinjection. Aesthetic Plast Surg. 2007 Sep-Oct;31(5):501-5. Epub 2007 Jul 25.</citation>
    <PMID>17653684</PMID>
  </reference>
  <reference>
    <citation>Hu S, Zhang H, Feng Y, Yang Y, Han X, Han X, Zhong Y, Shi J. Introduction of an easy technique for purification and injection of autogenous free fat parcels in correcting of facial contour deformities. Ann Plast Surg. 2007 Jun;58(6):602-7.</citation>
    <PMID>17522480</PMID>
  </reference>
  <reference>
    <citation>Kaufman MR, Bradley JP, Dickinson B, Heller JB, Wasson K, O'Hara C, Huang C, Gabbay J, Ghadjar K, Miller TA. Autologous fat transfer national consensus survey: trends in techniques for harvest, preparation, and application, and perception of short- and long-term results. Plast Reconstr Surg. 2007 Jan;119(1):323-31.</citation>
    <PMID>17255689</PMID>
  </reference>
  <reference>
    <citation>Sardesai MG, Moore CC. Quantitative and qualitative dermal change with microfat grafting of facial scars. Otolaryngol Head Neck Surg. 2007 Dec;137(6):868-72.</citation>
    <PMID>18036412</PMID>
  </reference>
  <reference>
    <citation>Coleman SR. Structural fat grafting: more than a permanent filler. Plast Reconstr Surg. 2006 Sep;118(3 Suppl):108S-120S.</citation>
    <PMID>16936550</PMID>
  </reference>
  <reference>
    <citation>Domergue S, Psomas C, Yachouh J, Lesnik A, Reynes J, Goudot P, Jammet P. Fat microinfiltration autografting for facial restructuring in HIV patients. J Craniomaxillofac Surg. 2006 Dec;34(8):484-8. Epub 2006 Dec 8.</citation>
    <PMID>17157518</PMID>
  </reference>
  <reference>
    <citation>Narins RS, Tope WD, Pope K, Ross EV. Overtreatment effects associated with a radiofrequency tissue-tightening device: rare, preventable, and correctable with subcision and autologous fat transfer. Dermatol Surg. 2006 Jan;32(1):115-24.</citation>
    <PMID>16393612</PMID>
  </reference>
  <reference>
    <citation>Pontius AT, Williams EF 3rd. The evolution of midface rejuvenation: combining the midface-lift and fat transfer. Arch Facial Plast Surg. 2006 Sep-Oct;8(5):300-5.</citation>
    <PMID>16982984</PMID>
  </reference>
  <reference>
    <citation>Burnouf M, Buffet M, Schwarzinger M, Roman P, Bui P, Prévot M, Deleuze J, Morini JP, Franck N, Gorin I, Dupin N. Evaluation of Coleman lipostructure for treatment of facial lipoatrophy in patients with human immunodeficiency virus and parameters associated with the efficiency of this technique. Arch Dermatol. 2005 Oct;141(10):1220-4.</citation>
    <PMID>16230558</PMID>
  </reference>
  <reference>
    <citation>Ellenbogen R, Motykie G, Youn A, Svehlak S, Yamini D. Facial reshaping using less invasive methods. Aesthet Surg J. 2005 Mar-Apr;25(2):144-52. doi: 10.1016/j.asj.2005.02.001.</citation>
    <PMID>19338805</PMID>
  </reference>
  <reference>
    <citation>Guaraldi G, Orlando G, De Fazio D, De Lorenzi I, Rottino A, De Santis G, Pedone A, Spaggiari A, Baccarani A, Borghi V, Esposito R. Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study. Antivir Ther. 2005;10(6):753-9.</citation>
    <PMID>16218175</PMID>
  </reference>
  <reference>
    <citation>Kanchwala SK, Holloway L, Bucky LP. Reliable soft tissue augmentation: a clinical comparison of injectable soft-tissue fillers for facial-volume augmentation. Ann Plast Surg. 2005 Jul;55(1):30-5; discussion 35.</citation>
    <PMID>15985788</PMID>
  </reference>
  <reference>
    <citation>Kuran I, Tumerdem B. A new simple method used to prepare fat for injection. Aesthetic Plast Surg. 2005 Jan-Feb;29(1):18-22; discussion 23. Epub 2005 Mar 10.</citation>
    <PMID>15759091</PMID>
  </reference>
  <reference>
    <citation>Ellenbogen R, Youn A, Yamini D, Svehlak S. The volumetric face lift. Aesthet Surg J. 2004 Nov-Dec;24(6):514-22. doi: 10.1016/j.asj.2004.08.006.</citation>
    <PMID>19336203</PMID>
  </reference>
  <reference>
    <citation>Karabulut AB, Tümerdem B. Obtaining predictable results in malar augmentation with preimplant fat injection. Plast Reconstr Surg. 2004 Dec;114(7):1974-5.</citation>
    <PMID>15577385</PMID>
  </reference>
  <reference>
    <citation>Serra-Renom JM, Fontdevila J. Treatment of facial fat atrophy related to treatment with protease inhibitors by autologous fat injection in patients with human immunodeficiency virus infection. Plast Reconstr Surg. 2004 Aug;114(2):551-5; discussion 556-7.</citation>
    <PMID>15277830</PMID>
  </reference>
  <reference>
    <citation>Dasiou-Plakida D. Fat injections for facial rejuvenation: 17 years experience in 1720 patients. J Cosmet Dermatol. 2003 Jul;2(3-4):119-25.</citation>
    <PMID>17163916</PMID>
  </reference>
  <reference>
    <citation>Sadick NS, Hudgins LC. Fatty acid analysis of transplanted adipose tissue. Arch Dermatol. 2001 Jun;137(6):723-7.</citation>
    <PMID>11405760</PMID>
  </reference>
  <reference>
    <citation>Berman M. Rejuvenation of the upper eyelid complex with autologous fat transplantation. Dermatol Surg. 2000 Dec;26(12):1113-6.</citation>
    <PMID>11134987</PMID>
  </reference>
  <reference>
    <citation>Cortese A, Savastano G, Felicetta L. Free fat transplantation for facial tissue augmentation. J Oral Maxillofac Surg. 2000 Feb;58(2):164-9; discussion 169-70.</citation>
    <PMID>10670595</PMID>
  </reference>
  <reference>
    <citation>Erol OO. Facial autologous soft-tissue contouring by adjunction of tissue cocktail injection (micrograft and minigraft mixture of dermis, fascia, and fat). Plast Reconstr Surg. 2000 Nov;106(6):1375-87; discussion 1388-9.</citation>
    <PMID>11083572</PMID>
  </reference>
  <reference>
    <citation>Reiche-Fischel O, Wolford LM, Pitta M. Facial contour reconstruction using an autologous free fat graft: a case report with 18-year follow-up. J Oral Maxillofac Surg. 2000 Jan;58(1):103-6.</citation>
    <PMID>10632174</PMID>
  </reference>
  <reference>
    <citation>Guerrerosantos J. Simultaneous rhytidoplasty and lipoinjection: a comprehensive aesthetic surgical strategy. Plast Reconstr Surg. 1998 Jul;102(1):191-9.</citation>
    <PMID>9655427</PMID>
  </reference>
  <reference>
    <citation>Robinson E, Rumsey N, Partridge J. An evaluation of the impact of social interaction skills training for facially disfigured people. Br J Plast Surg. 1996 Jul;49(5):281-9.</citation>
    <PMID>8774241</PMID>
  </reference>
  <reference>
    <citation>Sarwer DB, Crerand CE. Body image and cosmetic medical treatments. Body Image. 2004 Jan;1(1):99-111.</citation>
    <PMID>18089144</PMID>
  </reference>
  <reference>
    <citation>Perry S, Difede J, Musngi G, Frances AJ, Jacobsberg L. Predictors of posttraumatic stress disorder after burn injury. Am J Psychiatry. 1992 Jul;149(7):931-5.</citation>
    <PMID>1609874</PMID>
  </reference>
  <reference>
    <citation>Valente SM. Visual disfigurement and depression. Plast Surg Nurs. 2009 Jan-Mar;29(1):10-6; quiz 17-8. doi: 10.1097/01.PSN.0000347718.75285.23.</citation>
    <PMID>19289942</PMID>
  </reference>
  <reference>
    <citation>Levine E, Degutis L, Pruzinsky T, Shin J, Persing JA. Quality of life and facial trauma: psychological and body image effects. Ann Plast Surg. 2005 May;54(5):502-10.</citation>
    <PMID>15838211</PMID>
  </reference>
  <reference>
    <citation>Guyuron B, Majzoub RK. Facial augmentation with core fat graft: a preliminary report. Plast Reconstr Surg. 2007 Jul;120(1):295-302.</citation>
    <PMID>17572578</PMID>
  </reference>
  <reference>
    <citation>Bisson JI, Shepherd JP, Dhutia M. Psychological sequelae of facial trauma. J Trauma. 1997 Sep;43(3):496-500.</citation>
    <PMID>9314314</PMID>
  </reference>
  <reference>
    <citation>Balakrishnan C, Hashim M, Gao D. The effect of partial-thickness facial burns on social functioning. J Burn Care Rehabil. 1999 May-Jun;20(3):224-5.</citation>
    <PMID>10342476</PMID>
  </reference>
  <reference>
    <citation>Macgregor FC. Facial disfigurement: problems and management of social interaction and implications for mental health. Aesthetic Plast Surg. 1990 Fall;14(4):249-57.</citation>
    <PMID>2239515</PMID>
  </reference>
  <reference>
    <citation>Thompson A, Kent G. Adjusting to disfigurement: processes involved in dealing with being visibly different. Clin Psychol Rev. 2001 Jul;21(5):663-82. Review.</citation>
    <PMID>11434225</PMID>
  </reference>
  <reference>
    <citation>Wallis H, Renneberg B, Ripper S, Germann G, Wind G, Jester A. Emotional distress and psychosocial resources in patients recovering from severe burn injury. J Burn Care Res. 2006 Sep-Oct;27(5):734-41.</citation>
    <PMID>16998408</PMID>
  </reference>
  <reference>
    <citation>Yee A, Adjei N, Do J, Ford M, Finkelstein J. Do patient expectations of spinal surgery relate to functional outcome? Clin Orthop Relat Res. 2008 May;466(5):1154-61. doi: 10.1007/s11999-008-0194-7. Epub 2008 Mar 18.</citation>
    <PMID>18347892</PMID>
  </reference>
  <reference>
    <citation>Nguyen TD, Attkisson CC, Stegner BL. Assessment of patient satisfaction: development and refinement of a service evaluation questionnaire. Eval Program Plann. 1983;6(3-4):299-313.</citation>
    <PMID>10267258</PMID>
  </reference>
  <reference>
    <citation>Weissman MM, Bothwell S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry. 1976 Sep;33(9):1111-5.</citation>
    <PMID>962494</PMID>
  </reference>
  <reference>
    <citation>Watson D, Friend R. Measurement of social-evaluative anxiety. J Consult Clin Psychol. 1969 Aug;33(4):448-57.</citation>
    <PMID>5810590</PMID>
  </reference>
  <reference>
    <citation>Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999 Nov 10;282(18):1737-44.</citation>
    <PMID>10568646</PMID>
  </reference>
  <reference>
    <citation>Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. The PTSD Checklist: Reliability, validity and diagnostic utility. Paper presented at the Annual Meeting of the International Society for Traumatic Stress Studies; 1993, San Antonio, TX.</citation>
  </reference>
  <reference>
    <citation>Rosenberg, M. (1979). Conceiving the self. NY: Basic Books</citation>
  </reference>
  <reference>
    <citation>Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92-100.</citation>
    <PMID>16250744</PMID>
  </reference>
  <reference>
    <citation>Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989 Feb;56(2):267-83.</citation>
    <PMID>2926629</PMID>
  </reference>
  <reference>
    <citation>Procidano ME, Heller K. Measures of perceived social support from friends and from family: three validation studies. Am J Community Psychol. 1983 Feb;11(1):1-24.</citation>
    <PMID>6837532</PMID>
  </reference>
  <reference>
    <citation>Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.</citation>
    <PMID>1593914</PMID>
  </reference>
  <reference>
    <citation>Ware J, Kosinski M, Keller S. SF-36 Physical and mental heatlh summary scales: A users manual. 2nd ed. Boston: New England Medical Center, 1994</citation>
  </reference>
  <reference>
    <citation>Lawrence J, Heinberg LJ, Roca A, Munster AM, Fauerbach JA. Development and validation of the Satisfaction with Appearance Scale: assessing body image among burn-injured patients. Psychological Assessment 1998; 10: 64-70.</citation>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2013</study_first_submitted>
  <study_first_submitted_qc>April 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2013</study_first_posted>
  <results_first_submitted>November 10, 2016</results_first_submitted>
  <results_first_submitted_qc>May 10, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 12, 2017</results_first_posted>
  <last_update_submitted>June 9, 2017</last_update_submitted>
  <last_update_submitted_qc>June 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>J. Peter Rubin, MD</investigator_full_name>
    <investigator_title>Founding Chair Department of Plastic Surgery Professor of Surgery at the University of Pittsburgh School of Medicine</investigator_title>
  </responsible_party>
  <keyword>Craniomaxillofacial (CMF) Battle-injured (BI)</keyword>
  <keyword>Facial Trauma</keyword>
  <keyword>Fat Grafts</keyword>
  <keyword>Autogenous Fat Transfers (AFT)</keyword>
  <keyword>Wounded warriors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facial Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>It is the Principal Investigator's intention to make stored samples and subject de-identified information available to secondary investigators after all research study testing has been completed. These stored samples and associated subject information will not include subject identifiers.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment will come from subjects who have successfully completed IRB# PRO09060101 entitled “Structural Fat Grafting for Craniofacial Trauma”. These subjects have expressed a strong desire to participate in this study and have been asked to sign the Research Registry IRB#PRO07050333.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Repeat Facial Fat Grafting</title>
          <description>Repeat Fat grafting: treat 5 subjects from protocol IRB # PRO09060101 with an additional fat graft treatment to assess whether this will increase fat graft retention over time.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Repeat Facial Fat Grafting</title>
          <description>Repeat Fat grafting: Fat grafting is a minimally invasive clinical procedure that has been widely used by plastic surgeons within reconstructive surgery for many years. We treat 5 subjects from protocol (IRB # PRO09060101) with an additional fat graft treatment to assess whether this will increase fat graft retention over time. .</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>18 years or older</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Serial computer tomography imaging</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Facial Volume Score</title>
        <description>the facial volume and appearance grading scale evaluates each aesthetic region in the face based on both physical examination and 3D photography by the clinician. scale ranges from 1-3 where a score of 1 indicates an obvious contour defect; 2 shows a noticeable improvement in contour but not sufficient to impart a normal appearance; 3 represents a normal appearance and/or close approximation with a normal uninjured contralateral structure.</description>
        <time_frame>assessed at baseline (pre-op), days 7-21 post-op, 3 months post-op, and 9 months post-op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Facial Volume Score at Baseline</title>
            <description>facial volume score at baseline, pre-op</description>
          </group>
          <group group_id="O2">
            <title>Facial Volume Score at 7-21 Day PO</title>
            <description>facial volume score at 7-21 days post-operation</description>
          </group>
          <group group_id="O3">
            <title>Facial Volume Score at 3 Month PO</title>
            <description>facial volume score at 3 months post-operation</description>
          </group>
          <group group_id="O4">
            <title>Facial Volume Score at 9 Months PO</title>
            <description>facial volume score at 3 months post-operation</description>
          </group>
        </group_list>
        <measure>
          <title>Facial Volume Score</title>
          <description>the facial volume and appearance grading scale evaluates each aesthetic region in the face based on both physical examination and 3D photography by the clinician. scale ranges from 1-3 where a score of 1 indicates an obvious contour defect; 2 shows a noticeable improvement in contour but not sufficient to impart a normal appearance; 3 represents a normal appearance and/or close approximation with a normal uninjured contralateral structure.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.4"/>
                    <measurement group_id="O2" value="2.2" spread="0.5"/>
                    <measurement group_id="O3" value="2.2" spread="0.4"/>
                    <measurement group_id="O4" value="2.6" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serial Computed Tomography Imaging</title>
        <description>serial computed tomography images were collected to evaluate the volume of the defect</description>
        <time_frame>assessed at 7-21 days, 3 months and 9 months post op.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CT Imaging at 7-21 Days PO</title>
            <description>CT imaging at 7-21 days post-operation</description>
          </group>
          <group group_id="O2">
            <title>CT Imaging at 3 Months PO</title>
            <description>CT imaging at 3 months post-operation</description>
          </group>
          <group group_id="O3">
            <title>CT Imaging at 9 Months PO</title>
            <description>CT imaging at 9 months post-operation</description>
          </group>
        </group_list>
        <measure>
          <title>Serial Computed Tomography Imaging</title>
          <description>serial computed tomography images were collected to evaluate the volume of the defect</description>
          <units>volume, mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" spread="12.3"/>
                    <measurement group_id="O2" value="10.3" spread="9.1"/>
                    <measurement group_id="O3" value="12.4">one participant analyzed</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Repeat Facial Fat Grafting</title>
          <description>Repeat Fat grafting: treat 5 subjects from protocol IRB # PRO09060101 with an additional fat graft treatment to assess whether this will increase fat graft retention over time.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>bruising</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>swelling</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>J. Peter Rubin</name_or_title>
      <organization>University of Pittsburgh</organization>
      <phone>412-624-9703</phone>
      <email>rubipj@upmc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

